Volume 20, Issue 6 (Nov 2018)
Prior switching to a second-line nonsteroidal antiandrogen does not impact the therapeutic efficacy of abiraterone acetate in patients with metastatic castration-resistant prostate cancer: a real-world retrospective study
Jin-Ge Zhao1, Jian-Dong Liu1, Peng-Fei Shen1, Xin Tang2, Guang-Xi Sun1, Xing-Ming Zhang1, Jun-Ru Chen1, Kun-Peng Shu1, Ming Shi1, Hao Zeng1
Asian J Androl 20: 545-550; 10.4103/aja.aja_58_18
Abstract |Full Text | PDF PDF

National Comprehensive Cancer Network (NCCN) risk classification in predicting biochemical recurrence after radical prostatectomy: a retrospective cohort study in Chinese prostate cancer patients
Hua Xu1,2, Yao Zhu1,2, Bo Dai1,2, Ding-Wei Ye1,2
Asian J Androl 20: 551-554; 10.4103/aja.aja_52_18
Abstract |Full Text | PDF PDF

Risk of prostate cancer in men with spinal cord injury: A systematic review and meta-analysis
Arcangelo Barbonetti1, Settimio D’Andrea2, Alessio Martorella2, Giorgio Felzani1, Sandro Francavilla2, Felice Francavilla2
Asian J Androl 20: 555-560; 10.4103/aja.aja_31_18
Abstract |Full Text | PDF PDF

Prognostic role of chromogranin A in castration-resistant prostate cancer: A meta-analysis
Peng Hong, Run-Qi Guo, Gang Song, Kai-Wei Yang, Lei Zhang, Xue-Song Li, Kai Zhang, Li-Qun Zhou
Asian J Androl 20: 561-566; 10.4103/aja.aja_57_18
Abstract |Full Text | PDF PDF

The Institute of Urology, Peking University prostatectomy score: a simple preoperative classification of prostate cancer for predicting surgical difficulty and risk
Bing-Lei Ma, Lin Yao, Wei Yu, Yu Wang, Hai-Feng Song, Zhe-Nan Zhang, Si-Meng Lu, Qian Zhang, Zhi-Song He, Jie Jin, Li-Qun Zhou
Asian J Androl 20: 581-586; 10.4103/aja.aja_39_18
Abstract |Full Text | PDF PDF

Muscarinic acetylcholine receptor M1 mediates prostate cancer cell migration and invasion through hedgehog signaling
Qing-Qing Yin, Lin-Hui Xu, Mi Zhang, Chen Xu
Asian J Androl 20: 608-614; 10.4103/aja.aja_55_18
Abstract |Full Text | PDF PDF

Worsening of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio in patients with prostate cancer after androgen deprivation therapy
Ryo Oka1, Takanobu Utsumi1,2, Takumi Endo1, Masashi Yano1, Shuichi Kamijima1, Naoto Kamiya1, Hiroyoshi Suzuki1
Asian J Androl 20: 634-636; 10.4103/aja.aja_33_18
Full Text | PDF PDF

Volume 20, Issue 5 (Sep 2018)
Treatment strategy for metastatic prostate cancer with extremely high PSA level: reconsidering the value of vintage therapy
Yasutaka Yamada1,2, Shinichi Sakamoto2, Yoshiyasu Amiya1, Makoto Sasaki1, Takayuki Shima1, Akira Komiya2, Noriyuki Suzuki1, Koichiro Akakura3, Tomohiko Ichikawa2, Hiroomi Nakatsu1
Asian J Androl 20: 432-437; 10.4103/aja.aja_24_18
Abstract |Full Text | PDF PDF

Using the prostate imaging reporting and data system version 2 (PI-RIDS v2) to detect prostate cancer can prevent unnecessary biopsies and invasive treatment
Chang Liu1, Shi-Liang Liu1, Zhi-Xian Wang1, Kai Yu1, Chun-Xiang Feng1, Zan Ke2, Liang Wang2, Xiao-Yong Zeng1
Asian J Androl 20: 459-464; 10.4103/aja.aja_19_18
Abstract |Full Text | PDF PDF

The novel long noncoding RNA LOC283070 is involved in the transition of LNCaP cells into androgen-independent cells via its interaction with PHB2
Ying Zhang1, Li-Na Wang2, Ya-Ni Lin1, Yuan-Xin Xing1, Yu Shi3, Jian Zhao4, Wei-Wen Chen1, Bo Han5
Asian J Androl 20: 511-517; 10.4103/aja.aja_36_18
Abstract |Full Text | PDF PDF